Exercise intolerance, or the inability to perform physical activity at the expected or desired level, is one of the many symptoms associated with long COVID. In a study, Yale researchers help explain what is explicitly driving ...
Dec 19, 2023
0
32
Targeting a master-regulator of inflammation with a monoclonal antibody potentially improves two unrelated conditions that currently have limited treatment options: preterm births and fatty liver disease, two new studies ...
Jun 22, 2023
0
81
A new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international multicenter trial involving researchers at UCL and University College London Hospitals ...
Jan 18, 2023
0
42
In a study appearing today in JAMA Network Open, Rady Children's Institute for Genomic Medicine (RCIGM) researchers found that the contribution of genetic diseases to infant deaths was higher than previously recognized. Of ...
Feb 9, 2023
0
70
A single infusion of chimeric antigen receptor T-cell (CAR-T) therapy induced complete response or remission in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), ...
Jul 14, 2023
0
64
Despite the prevalence of the painful condition, women are fearful and frustrated with limited management options, according to Cedars-Sinai research published in the Journal of Urology.
Oct 1, 2021
0
33
A test of protein in the blood is receiving further support as a biomarker for patients diagnosed with frontotemporal dementia (FTD), a group of brain disorders with few treatment options. These disorders are characterized ...
Apr 19, 2022
0
26
October is Breast Cancer Awareness Month, which makes this a good time to learn more about metastatic breast cancer.
Oct 6, 2021
0
4
In clinical practice guidelines issued by the Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society, and published online Oct. 11 in the Journal of Vascular Surgery: Venous and Lymphatic ...
Dec 15, 2022
0
9
Immune-checkpoint inhibitors have become the standard of care for patients with advanced melanoma to improve survival, but only some patients respond to this immunotherapy and have long-term benefits. The lack of a long-lasting ...
Aug 7, 2023
0
36
